Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 28, 2026 | Promising Preclinical Data Support TPC-026 as a Novel Chronic Therapy for Metabolic Disorders Including Obesity | Promising Preclinical Data Support TPC-026 as a Novel Chronic Therapy for Metabolic Disorders Including Obesity Wed, Jan 28, 2026 06:56 CET Report this content Press release Copenhagen, Denmark, 28 January 2026. TETRAPHARM, a Copenhagen-bas... |
| Mar 13, 2025 | DanCann Pharma A/S forges cutting edge alliance with Tetra Pharm Technologies ApS | DanCann Pharma A/S forges cutting edge alliance with Tetra Pharm Technologies ApS Thu, Mar 13, 2025 13:00 CET Report this content COPENHAGEN, Denmark, 13 March 2025 – DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "... |
| May 30, 2024 | Tetra Pharm Technologies and Kvantify Announce Partnership to Accelerate the Discovery of Novel Drug Candidates Targeting the Endocannabinoid System | The collaboration between two Danish companies aims to revolutionize drug discovery with help from quantum computing, AI and computer-aided drug design. COPENHAGEN, Denmark, May 30, 2024 /PRNewswire/ -- Tetra Pharm Technologies and Kvantify... |
Reviews 0
FAQ about tetrapharm.eu
What has the press written about tetrapharm.eu?
Parsers VC has collected 4 articles mentioning tetrapharm.eu, among them “Promising Preclinical Data Support TPC-026 as a Novel Chronic Therapy for Metabolic Disorders Including Obesity” (Jan 28, 2026) and “DanCann Pharma A/S forges cutting edge alliance with Tetra Pharm Technologies ApS” (Mar 13, 2025).
Is tetrapharm.eu still active?
Yes, tetrapharm.eu is active; its latest activity on Parsers VC dates from Oct 9, 2026.